MAPT and Alzheimer disease: Moreover, a previous report has also revealed that elevated levels of GSK3β in AD-affected tissues activate VDAC1 phosphorylation in mitochondria [64] causing mitochondrial dysfunction, and increased Aβ production and hyperphosphorylation of tau leading to synaptic damage [16].